GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Ppargc1a | increases expression | EXP | | 6480464 | CTD | Triiodothyronine results in increased expression of PPARGC1A mRNA | PMID:30209975 | Ppargc1a | multiple interactions | EXP | | 6480464 | CTD | [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of PPARGC1A mRNA; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of PPARGC1A protein | PMID:33091441 | Ppargc1a | increases expression | ISO | Ppargc1a (Rattus norvegicus) | 6480464 | CTD | Triiodothyronine results in increased expression of PPARGC1A mRNA | PMID:23209300 | Ppargc1a | multiple interactions | ISO | PPARGC1A (Homo sapiens) | 6480464 | CTD | [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA] | PMID:33476690 | |
Go Back to source page | Continue to Ontology report |